What does CUSIP 92764N102 represent in this 13F holders report?

CUSIP 92764N102 is the security identifier for VIR - Vir Biotechnology, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VIR - Vir Biotechnology, Inc. - Common Stock in Q2 2021?

156 institutional investors reported VIR - Vir Biotechnology, Inc. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

Vir Biotechnology, Inc. - Common Stock (VIR)

CUSIP: 92764N102

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 159,883,161
Total 13F shares: 74,156,851
Share change: +1,458,555
Total reported value: $3,506,017,317
Put/Call ratio: 43%
Price per share: $47.28
Number of holders: 156
Value change: +$66,755,814
Number of buys: 95
Number of sells: 57

Quarterly Holders Quick Answers

What is CUSIP 92764N102?
CUSIP 92764N102 identifies VIR - Vir Biotechnology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 92764N102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	14%	22,616,666	$1,159,556,000	—	31 Mar 2021	13F
Capital International Investors	13F	Company	7.4%	11,822,763	$606,153,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	3.7%	5,938,114	$304,447,000	—	31 Mar 2021	13F
Temasek Holdings (Private) Ltd	13F	Company	3.5%	5,518,644	$282,941,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	3.3%	5,285,435	$270,984,000	—	31 Mar 2021	13F
BAILLIE GIFFORD & CO	13F	Company	2.4%	3,817,148	$195,705,000	—	31 Mar 2021	13F
Alaska Permanent Fund Corp	13F	Company	2.4%	3,800,000	$194,826,000	—	31 Mar 2021	13F
Gates Foundation	13F	Company	1.7%	2,777,777	$142,417,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	1.2%	1,878,727	$96,322,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.1%	1,798,779	$92,223,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.67%	1,077,422	$55,239,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.62%	999,142	$51,226,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.38%	604,621	$30,999,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.35%	557,172	$28,567,000	—	31 Mar 2021	13F
Taikang Asset Management (Hong Kong) Co Ltd	13F	Company	0.33%	533,332	$27,344,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.32%	505,527	$25,918,000	—	31 Mar 2021	13F
ORACLE INVESTMENT MANAGEMENT INC	13F	Company	0.28%	450,331	$23,088,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.25%	402,641	$20,643,000	—	31 Mar 2021	13F
MWG Management Ltd.	13F	Company	0.2%	325,000	$16,663,000	—	31 Mar 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.18%	283,769	$14,549,000	—	31 Mar 2021	13F
Bank Julius Baer & Co. Ltd, Zurich	13F	Company	0.16%	251,996	$12,920,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	231,127	$11,850,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.13%	210,139	$10,773,000	—	31 Mar 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.13%	208,260	$10,677,000	—	31 Mar 2021	13F
ALPS ADVISORS INC	13F	Company	0.13%	206,416	$10,583,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.11%	178,786	$9,166,000	—	31 Mar 2021	13F
NATIXIS	13F	Company	0.11%	173,110	$8,875,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.11%	171,306	$8,782,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	141,932	$7,277,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.07%	116,292	$5,962,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.14%	226,238	$5,820,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	0.07%	106,594	$5,464,000	—	31 Mar 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.06%	101,716	$5,215,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.06%	95,191	$4,880,000	—	31 Mar 2021	13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	13F	Company	0.06%	94,513	$4,846,000	—	31 Mar 2021	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.06%	89,428	$4,584,000	—	31 Mar 2021	13F
Tekla Capital Management LLC	13F	Company	0.05%	81,400	$4,173,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	80,792	$4,142,000	—	31 Mar 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.05%	78,600	$4,030,000	—	31 Mar 2021	13F
Capital International, Inc./CA/	13F	Company	0.04%	65,586	$3,363,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.04%	61,979	$3,178,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	60,385	$3,096,000	—	31 Mar 2021	13F
HRT FINANCIAL LP	13F	Company	0.03%	53,638	$2,750,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	48,500	$2,487,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.03%	48,070	$2,465,000	—	31 Mar 2021	13F
CAPITAL INTERNATIONAL LTD /CA/	13F	Company	0.03%	47,739	$2,448,000	—	31 Mar 2021	13F
PATHWAY CAPITAL MANAGEMENT, LP	13F	Company	0.03%	47,255	$2,423,000	—	31 Mar 2021	13F
SG Americas Securities, LLC	13F	Company	0.03%	41,927	$2,150,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	41,830	$2,145,000	—	31 Mar 2021	13F
ROTHSCHILD INVESTMENT LLC /IL	13F	Company	0.03%	41,450	$2,125,000	—	31 Mar 2021	13F

Institutional Holders of Vir Biotechnology, Inc. - Common Stock (VIR) as of Q2 2021

As of 30 Jun 2021, Vir Biotechnology, Inc. - Common Stock (VIR) was held by 156 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,156,851 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, Capital International Investors, VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, BlackRock Inc., BAILLIE GIFFORD & CO, Alaska Permanent Fund Corp, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 157 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

151

Q2 2021 holders

156

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.